Following the enhancement of NANOG expression, there appeared increased expressions of BMI and SNAIL1/2, followed by the suppression of E-cadherin expression in various cancer cells (glioblastoma, non-small lung cancer, HNSC, colon cancer, and A549). Here, NANOG is linked to malignant colon neoplasm.